Redesigned Guidepoint TRACKER Website Launched
For the first time since the Guidepoint TRACKER website launch in 2007, a redesigned portal is being rolled out. Clients can use either the old or new website for the initial period while the launch is phased in. Graphs, tables and controls will retain a familiar look, but stay tuned, more to come.
Let us know what you think:
Feedback & Suggestions, Access, Data Questions, Tech Support
Supplementary Data – Have you seen it?
The Guidepoint TRACKER analyst team often collects data through directed questions addressing emerging market dynamics. This data can be found in the Supplementary section.
Recent examples: US Transcatheter TRACKER patient risk stratification since Aug 2016 and in Sept 2016 following Pharming’s Rhucin/Ruconest rights reacquisition announcement, a series of HAE TRACKER questions focused on awareness, perception, future use and more.
Panel expansion for the CRC Screening TRACKER is underway with new site data expected to be available mid-H1 ‘17. Other recent expansions include Dermal Fillers and Neurotoxins (Aug 2016), US PAH (Jun 2015) US CRM (May 2015) and Cochlear Implants (Jan 2015).